View More View Less
  • 1 Onkoterápiás Klinika, Szegedi Tudományegyetem, 6725, Szeged, Korányi fasor 12.
Restricted access
  • 1. Early Breast Cancer Trialists' Collaborative Group 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials Lancet 365 1687 1717.

    • Search Google Scholar
    • Export Citation
  • 2. R Jakesz R Greil M Gnant et al.2007 Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a J Natl Cancer Inst 99 1845 1853.

    • Search Google Scholar
    • Export Citation
  • 3. PE Goss JN Ingle S Martino et al.2003 A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer N Engl J Med 349 1793 1802.

    • Search Google Scholar
    • Export Citation
  • 4. PE Goss JN Ingle S Martino et al.2005 Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17 J Natl Cancer Inst 97 1262 1271.

    • Search Google Scholar
    • Export Citation
  • 5. EP Winer C Hudis HJ Burstein et al.2005 American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004 J Clin Oncol 23 619 629.

    • Search Google Scholar
    • Export Citation
  • 6. B Fischer J Dignam J Bryant N Wolmark 2001 Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial J Natl Cancer Inst 93 684 690.

    • Search Google Scholar
    • Export Citation
  • 7. Peto R , Davies C. ATLAS (Adjuvant Tamoxifen, Longer Against Shorter): International randomized trial of 10 versus 5 years of adjuvant tamoxifen among 11500 women – preliminary results. 2007; SABCS, abstr. 48.

    • Search Google Scholar
    • Export Citation
  • 8. M Jahanzeb 2007 Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women Clin Ther 29 1535 1547.

    • Search Google Scholar
    • Export Citation
  • 9. The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group 2008 Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial Lancet 9 45 53.

    • Search Google Scholar
    • Export Citation

Magyar Onkológia
Language Hungarian
Size  
Year of
Foundation
1956
Publication
Programme
 
Volumes
per Year
 
Issues
per Year
 
Founder Magyar Onkológusok Társasága
Founder's
Address
H-1122 Budapest, Hungary Ráth György u. 7-9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0025-0244 (Print)
ISSN 2060-0399 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2021 2 0 0
Jun 2021 2 0 0
Jul 2021 6 0 0
Aug 2021 41 0 0
Sep 2021 1 0 1
Oct 2021 0 0 0
Nov 2021 0 0 0